294 related articles for article (PubMed ID: 16277922)
1. [Treatment of rectal cancer].
Bülow S; Rasmussen PC; Jakobsen AK
Ugeskr Laeger; 2005 Nov; 167(45):4255-7. PubMed ID: 16277922
[TBL] [Abstract][Full Text] [Related]
2. Rectal cancer.
Zampino MG; Labianca R; Beretta GD; Magni E; Gatta G; Leonardi MC; Chiappa A; Biffi R; de Braud F; Wils J
Crit Rev Oncol Hematol; 2009 May; 70(2):160-82. PubMed ID: 19059790
[TBL] [Abstract][Full Text] [Related]
3. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
Daniels IR; Fisher SE; Heald RJ; Moran BJ
Colorectal Dis; 2007 May; 9(4):290-301. PubMed ID: 17432979
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Rectal cancer radiotherapy.
Ramsey S; Tepper JE
Cancer J; 2007; 13(3):204-9. PubMed ID: 17620771
[TBL] [Abstract][Full Text] [Related]
6. Preoperative decision making for rectal cancer.
Taflampas P; Christodoulakis M; de Bree E; Melissas J; Tsiftsis DD
Am J Surg; 2010 Sep; 200(3):426-32. PubMed ID: 20223450
[TBL] [Abstract][Full Text] [Related]
7. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
8. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
9. The surgical approach to locally recurrent rectal cancer.
Spiliotis J; Datsis A
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s33-5. PubMed ID: 15655636
[TBL] [Abstract][Full Text] [Related]
10. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
11. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
12. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of locally recurrent rectal cancer].
Wiig JN; Dueland S; Larsen S; Giercksky KE
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3097-101. PubMed ID: 18049503
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
16. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
17. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy of rectal cancer].
Balteskard L; Vonen B; Frykholm G; Dahl O; Tveit KM
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3090-3. PubMed ID: 18049501
[TBL] [Abstract][Full Text] [Related]
19. Management and imaging of low rectal carcinoma.
Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
[TBL] [Abstract][Full Text] [Related]
20. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
